Method and apparatus for detecting and discriminating tachycardia in a subcutaneously implantable cardiac device

Patent metadata

Field	Value
Publication number	US-9682238-B2
Application number	US-201514876129-A
Country	US
Kind code	B2
Filing date	Oct 6, 2015
Priority date	Apr 28, 2010
Publication date	Jun 20, 2017
Grant date	Jun 20, 2017

Abstract

A medical device and associated method for discriminating cardiac events includes sensing a cardiac signal spatially located across approximately a full duration of a predetermined sensing window. A match score is determined corresponding to the sensed cardiac signal. A beat feature of multiple beat features across less than the full duration of the sensing window is determined, the beat feature being selected from the multiple beat features in response to the match score. Cardiac event evidence is accumulated in response to the match score and the determined beat feature, and cardiac events are discriminated in response to the accumulated cardiac evidence.

First claim

The invention claimed is:

1. A medical device for discriminating cardiac events, comprising:
a subcutaneously implantable lead having a lead body;
a subcutaneously implantable housing electrically coupled to the lead body;
a plurality of subcutaneously implantable electrodes positioned along the lead body and the housing to sense a first cardiac signal and a second cardiac signal; and
a processor within the housing configured to:
determine a first match score corresponding to a beat within the first cardiac signal;
determine within which one of a plurality of match zones the first match score is, wherein the plurality of match zones includes a first match zone corresponding to a first, non-treatable cardiac event, and a second match zone corresponding to a second, treatable cardiac event different from the first cardiac event;
determine a second match score corresponding to the beat within the second cardiac signal;
determine within which one of the plurality of match zones the second match score is;
determine an amount to increase or decrease an event counter based on both within which of the plurality of match zones the first match score is and within which of the plurality of match zones the second match score is;
adjust the event counter by the determined amount;
determine whether a current cardiac event that includes the beat is a treatable cardiac event or a non-treatable cardiac event based on the adjusted event counter; and
control the medical device to deliver therapy in response to determining that the current cardiac event is the treatable cardiac event.

2. The device of claim 1 , wherein the first match score corresponds to a morphology of the first cardiac signal and the second match score corresponds to a morphology of the second cardiac signal.

3. The device of claim 1 , wherein the first cardiac signal corresponds to a far field sensing vector formed between electrodes of the plurality of electrodes and the second cardiac signal corresponds to a near field sensing vector formed between electrodes of the plurality of electrodes.

4. The device of claim 3 , wherein the first match zone has a first correlation with the, first non-treatable cardiac event, and the plurality of match zones further comprises a third match zone that has a second correlation with the first, non-treatable cardiac event less than the first correlation.

5. The device of claim 4 , wherein the first, non-treatable cardiac event corresponds to supraventricular tachycardia and the second, treatable cardiac event corresponds to ventricular tachycardia.

6. The device of claim 4 , wherein the processor is configured to:
decrease the event counter by a first value based on the first match score being in the first match zone and the second match score being within one of the first match zone and the third match zone; and
decrease the event counter by a second value less than the first value based on the first match score being in the first match zone and the second match score being in the second match zone.

7. The device of claim 4 , wherein the processor is configured to:
increase the event counter based on the first match score being in the third match zone and the second match score being in the second match zone; and
decrease the event counter based on the first match score being in the third match zone and the second match score being within one of the first match zone and the third match zone.

8. The device of claim 4 , wherein the processor is configured to determine beat features of the first cardiac signal in response to the first match score being in the third match zone, and adjust the first match score in response to the determined beat features.

9. The device of claim 4 , wherein the second match zone has a first correlation with the second, treatable cardiac event, wherein the plurality of match zones further comprises a fourth match zone corresponding to the second, treatable cardiac event, and wherein the fourth match zone has a second correlation with the second, treatable cardiac event greater than the first correlation with the second, treatable cardiac event.

10. The device of claim 9 , wherein the processor is configured to:
decrease the event counter based on the first match score being in the third match zone and the second match score being in the fourth match zone; and
increase the event counter based on the first match score being in the third match zone and the second match score not being in the fourth match zone.

11. The device of claim 9 , wherein the processor is configured to:
increase the event counter by a first value based on the first match score being in the first match zone and the second match score being in the first match zone; and
increase the event counter by a second value less than the first value based on the first match score being in the first match zone and the second match score being in one of the second match zone, the third match zone and the fourth match zone.

12. The device of claim 9 , wherein the first, non-treatable event corresponds to a supraventricular tachycardia event and the second, treatable cardiac event corresponds to ventricular tachycardia.

13. The device of claim 9 , wherein the processor is configured to determine beat features of the first cardiac signal in response to the first match score being in the third match zone, and adjust the first match score in response to the determined beat features.

14. A method for discriminating cardiac events with a medical device comprising a subcutaneously implantable lead having a lead body, a subcutaneously implantable housing electrically coupled to the lead body, a plurality of subcutaneously implantable electrodes positioned along the lead body and the housing to sense a first cardiac signal and a second cardiac signal, and a processor within the housing, the method comprising:
determining, by the processor, a first match score corresponding to a beat within the first cardiac signal;
determining, by the processor, within which one of a plurality of match zones the first match score is, wherein the plurality of match zones includes a first match zone corresponding to a first, non-treatable cardiac event, and a second match zone corresponding to a second, treatable cardiac event different from the first cardiac event;
determining, by the processor, a second match score corresponding to the beat within the second cardiac signal;
determining, by the processor, within which one of the plurality of match zones the second match score is;
determining, by the processor, an amount to increase or decrease an event counter based on both within which of the plurality of match zones the first match score is and within which of the plurality of match zones the second match score is;
determining, by the processor, whether a current cardiac event that includes the beat is a treatable cardiac event or a non-treatable cardiac event based on the adjusted event counter; and
controlling, by the processor, the medical device to deliver therapy in response to determining that the current cardiac event is the treatable cardiac event.

15. The method of claim 14 ,
wherein the first match score corresponds to a morphology of the first cardiac signal and the second match score corresponds to a morphology of the second cardiac signal,
wherein the first cardiac signal corresponds to a far field sensing vector formed between electrodes of the plurality of electrodes and the second cardiac signal corresponds to a near field sensing vector formed between electrodes of the plurality of electrodes, and
wherein the first, non-tr

Assignees

• Medtronic Inc

Inventors

• Zhang Xusheng
• Stadler Robert W
• Gillberg Jeffrey M

Classifications

• A61B5/02405 Primary

  Determining heart rate variability · CPC title

• A61N1/39622

  Pacing therapy · CPC title

• A61B5/7203

  for noise prevention, reduction or removal · CPC title

• A61N1/3621

  for treating or preventing abnormally high heart rate · CPC title

• A61N1/3962

  in combination with another heart therapy · CPC title